OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ARCT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Arcturus Therapeutics Holdings (ARCT) Earnings Date & Reports

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ARCT is expected to report earnings to fall 1,726.47% to $5.53 per share on November 05

Arcturus Therapeutics Holdings ARCT Stock Earnings Reports

Q3'25

Est.

$5.53

Q2'25

Missed

by $3.55

Q1'25

Missed

by $4.11

Q4'24

Missed

by $0.92

Q3'24

Beat

by $0.31

The last earnings report on August 11 showed earnings per share of -34 cents, missing the estimate of $3.21. With 994.18K shares outstanding, the current market capitalization sits at 528.97M.

View a ticker or compare two or three

Compare

ARCT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ARCT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARCT showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of technology and therapeutics for rare diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

10628 Science Center Drive

Phone

+1 858 900-2660

Employees

180

Web

https://www.arcturusrx.com